180 related articles for article (PubMed ID: 18467700)
1. Myofilament degradation and dysfunction of human cardiomyocytes in Fabry disease.
Chimenti C; Hamdani N; Boontje NM; DeCobelli F; Esposito A; Bronzwaer JG; Stienen GJ; Russo MA; Paulus WJ; Frustaci A; van der Velden J
Am J Pathol; 2008 Jun; 172(6):1482-90. PubMed ID: 18467700
[TBL] [Abstract][Full Text] [Related]
2. Increased oxidative stress contributes to cardiomyocyte dysfunction and death in patients with Fabry disease cardiomyopathy.
Chimenti C; Scopelliti F; Vulpis E; Tafani M; Villanova L; Verardo R; De Paulis R; Russo MA; Frustaci A
Hum Pathol; 2015 Nov; 46(11):1760-8. PubMed ID: 26362204
[TBL] [Abstract][Full Text] [Related]
3. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
Duncker DJ; Boontje NM; Merkus D; Versteilen A; Krysiak J; Mearini G; El-Armouche A; de Beer VJ; Lamers JM; Carrier L; Walker LA; Linke WA; Stienen GJ; van der Velden J
Circ Heart Fail; 2009 May; 2(3):233-42. PubMed ID: 19808345
[TBL] [Abstract][Full Text] [Related]
4. Early detection of Fabry cardiomyopathy by tissue Doppler imaging.
Pieroni M; Chimenti C; Ricci R; Sale P; Russo MA; Frustaci A
Circulation; 2003 Apr; 107(15):1978-84. PubMed ID: 12668521
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural Evidence of Glycosphingolipid Degradation After Enzyme Replacement Therapy in Patients With Fabry Disease.
Onoue K; Takemura G; Nakano T; Miyazaki N; Tsujimoto A; Watanabe T; Okada H; Kanamori H; Sugiura J; Kanaoka K; Ishihara S; Horii M; Akai Y; Sakaguchi Y; Saito Y
Circ J; 2019 Sep; 83(10):2081. PubMed ID: 30930427
[No Abstract] [Full Text] [Related]
6. Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy.
Aguiar P; Azevedo O; Pinto R; Marino J; Cardoso C; Sousa N; Cunha D; Hughes D; Ducla Soares JL
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29535138
[TBL] [Abstract][Full Text] [Related]
7. Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium.
van der Velden J; Narolska NA; Lamberts RR; Boontje NM; Borbély A; Zaremba R; Bronzwaer JG; Papp Z; Jaquet K; Paulus WJ; Stienen GJ
Cardiovasc Res; 2006 Mar; 69(4):876-87. PubMed ID: 16376870
[TBL] [Abstract][Full Text] [Related]
8. Selective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model.
Najafi A; Sequeira V; Helmes M; Bollen IA; Goebel M; Regan JA; Carrier L; Kuster DW; Van Der Velden J
Cardiovasc Res; 2016 May; 110(2):200-14. PubMed ID: 26825555
[TBL] [Abstract][Full Text] [Related]
9. Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction.
van der Velden J; Merkus D; Klarenbeek BR; James AT; Boontje NM; Dekkers DH; Stienen GJ; Lamers JM; Duncker DJ
Circ Res; 2004 Nov; 95(11):e85-95. PubMed ID: 15528471
[TBL] [Abstract][Full Text] [Related]
10. Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I.
Layland J; Cave AC; Warren C; Grieve DJ; Sparks E; Kentish JC; Solaro RJ; Shah AM
FASEB J; 2005 Jul; 19(9):1137-9. PubMed ID: 15855227
[TBL] [Abstract][Full Text] [Related]
11. Later Onset Fabry Disease, Cardiac Damage Progress in Silence: Experience With a Highly Prevalent Mutation.
Hsu TR; Hung SC; Chang FP; Yu WC; Sung SH; Hsu CL; Dzhagalov I; Yang CF; Chu TH; Lee HJ; Lu YH; Chang SK; Liao HC; Lin HY; Liao TC; Lee PC; Li HY; Yang AH; Ho HC; Chiang CC; Lin CY; Desnick RJ; Niu DM
J Am Coll Cardiol; 2016 Dec; 68(23):2554-2563. PubMed ID: 27931613
[TBL] [Abstract][Full Text] [Related]
12. Correlations between Endomyocardial Biopsies and Cardiac Manifestations in Taiwanese Patients with the Chinese Hotspot IVS4+919G>A Mutation: Data from the Fabry Outcome Survey.
Hsu TR; Chang FP; Chu TH; Sung SH; Bizjajeva S; Yu WC; Niu DM
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28075357
[TBL] [Abstract][Full Text] [Related]
13. Evolution of cardiac pathology in classic Fabry disease: Progressive cardiomyocyte enlargement leads to increased cell death and fibrosis, and correlates with severity of ventricular hypertrophy.
Frustaci A; Chimenti C; Doheny D; Desnick RJ
Int J Cardiol; 2017 Dec; 248():257-262. PubMed ID: 28688718
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
[TBL] [Abstract][Full Text] [Related]
15. Cardiac and skeletal myopathy in Fabry disease: a clinicopathologic correlative study.
Chimenti C; Padua L; Pazzaglia C; Morgante E; Centurion C; Antuzzi D; Russo MA; Frustaci A
Hum Pathol; 2012 Sep; 43(9):1444-52. PubMed ID: 22406371
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function.
Haworth RS; Cuello F; Herron TJ; Franzen G; Kentish JC; Gautel M; Avkiran M
Circ Res; 2004 Nov; 95(11):1091-9. PubMed ID: 15514163
[TBL] [Abstract][Full Text] [Related]
17. Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart.
Fentzke RC; Buck SH; Patel JR; Lin H; Wolska BM; Stojanovic MO; Martin AF; Solaro RJ; Moss RL; Leiden JM
J Physiol; 1999 May; 517 ( Pt 1)(Pt 1):143-57. PubMed ID: 10226156
[TBL] [Abstract][Full Text] [Related]
18. Myofilament dysfunction in cardiac disease from mice to men.
Hamdani N; de Waard M; Messer AE; Boontje NM; Kooij V; van Dijk S; Versteilen A; Lamberts R; Merkus D; Dos Remedios C; Duncker DJ; Borbely A; Papp Z; Paulus W; Stienen GJ; Marston SB; van der Velden J
J Muscle Res Cell Motil; 2008; 29(6-8):189-201. PubMed ID: 19140019
[TBL] [Abstract][Full Text] [Related]
19. Length-dependent activation is modulated by cardiac troponin I bisphosphorylation at Ser23 and Ser24 but not by Thr143 phosphorylation.
Wijnker PJ; Sequeira V; Foster DB; Li Y; Dos Remedios CG; Murphy AM; Stienen GJ; van der Velden J
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1171-81. PubMed ID: 24585778
[TBL] [Abstract][Full Text] [Related]
20. Fabry disease - Vascular manifestations.
Karetova D; Bultas J; Dostalova G; Palecek T; Kovarnik T; Golan L; Linhart A
Vasa; 2010 May; 39(2):123-31. PubMed ID: 20464667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
